Robert J. Gyurik
Plus aucun poste en cours
Profil
Robert J.
Gyurik has been a Director of Bentley Pharmaceuticals, Inc. since 1998 and became Vice President of Pharmaceutical Development in March 1999.
Prior to joining Bentley, he was Manager of Development and Quality Control at MacroChem Corporation from May 1993 to February 1999.
From 1971 to 1993, he worked in various research and development positions at SmithKline Beecham.
Prior thereto, he worked at Schering as a Medicinal Chemist.
Mr. Gyurik holds a BA in Biology and Chemistry.
Anciens postes connus de Robert J. Gyurik
| Sociétés | Poste | Fin |
|---|---|---|
Teva Spanish Holdco, Inc.
 Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Directeur/Membre du Conseil | 22/07/2008 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Teva Spanish Holdco, Inc.
Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Health Technology |
